0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

The Global Exosome Market: Size, Forecast, Trials, and Trends, 2024 - Product Thumbnail Image

The Global Exosome Market: Size, Forecast, Trials, and Trends, 2024

  • Report
  • September 2024
  • 351 Pages
  • Global
From
EUR$4,197USDGBP
Myelodysplastic Syndrome Market Report 2025 - Product Thumbnail Image

Myelodysplastic Syndrome Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Autoimmune Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2025

  • Report
  • April 2025
  • 500 Pages +
  • Global
From
EUR$3,995USDGBP
From
EUR$3,825USDGBP
EUR$4,500USDGBP
Leukemia Therapeutics Market Report 2025 - Product Thumbnail Image

Leukemia Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
From
EUR$4,490USDGBP
Systemic Lupus Erythematosus - Pipeline Review, H2 2020 - Product Thumbnail Image

Systemic Lupus Erythematosus - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 816 Pages
  • Global
From
EUR$2,500USDGBP
Acute Myeloid Leukemia Market Report 2025 - Product Thumbnail Image

Acute Myeloid Leukemia Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
From
EUR$2,000USDGBP
Pruritus Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Pruritus Therapeutics - Global Strategic Business Report

  • Report
  • June 2025
  • 192 Pages
  • Global
From
EUR$5,850USDGBP
Atrial Fibrillation - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Atrial Fibrillation - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • November 2021
  • 929 Pages
  • Global
From
EUR$2,500USDGBP
Inactivated Vaccines - Global Strategic Business Report - Product Thumbnail Image

Inactivated Vaccines - Global Strategic Business Report

  • Report
  • June 2025
  • 468 Pages
  • Global
From
EUR$5,850USDGBP
DNA Vaccines - Global Strategic Business Report - Product Thumbnail Image

DNA Vaccines - Global Strategic Business Report

  • Report
  • June 2025
  • 171 Pages
  • Global
From
EUR$5,850USDGBP
Bacterial Vaccines - Global Strategic Business Report - Product Thumbnail Image

Bacterial Vaccines - Global Strategic Business Report

  • Report
  • June 2025
  • 490 Pages
  • Global
From
EUR$5,850USDGBP
Polio Vaccines - Global Strategic Business Report - Product Thumbnail Image

Polio Vaccines - Global Strategic Business Report

  • Report
  • June 2025
  • 277 Pages
  • Global
From
EUR$5,850USDGBP
From
EUR$4,750USDGBP
From
EUR$2,500USDGBP
From
EUR$4,750USDGBP
Loading Indicator
This website uses cookies to ensure you get the best experience. Learn more